Dehydration (Physiology) Completed Phase 4 Trials for Hyaluronidase (human recombinant) (DB06205)

Also known as: Dehydration / Fluid volume deficit (finding) / Exsiccosis / Dehydration (disorder)

Indication	Status	Phase
DBCOND0116068 (Dehydration (Physiology))	Completed	4

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT00477152	Study of Subcutaneous Rehydration With Recombinant Human Hyaluronidase for Infants and Children	Treatment	Hyaluronidase (human recombinant) (DB06205)
NCT00773175	Subcutaneous Rehydration Compared to Intravenous Rehydration	Treatment	Hyaluronidase (human recombinant) (DB06205)
NCT00807885	Study of Techniques of Subcutaneous Administration of Fluids Enabled by Human Recombinant Hyaluronidase	Treatment	Calcium chloride (DB01164) Hyaluronidase (human recombinant) (DB06205) Lactic acid (DB04398) Potassium chloride (DB00761) Sodium chloride (DB09153)